Metronomic continuous oral cyclophosphamide as second and further line in soft-tissue sarcomas (STS) of the adult

Autor: F. Garetto, Alessandra Linari, Simona Chiadò Cutin, M. Turbiglio, Antonella Boglione, Orietta Dal Canton, Alessandro Comandone, Raimondo Piana, Elena Giubellino, P. Pazienza, G. Gino, P. Pochettino, P. Bergnolo, C. Oliva, Davide Ottaviani, Elena Maria Brach Del Prever
Rok vydání: 2013
Předmět:
Zdroj: Journal of Clinical Oncology. 31:10572-10572
ISSN: 1527-7755
0732-183X
DOI: 10.1200/jco.2013.31.15_suppl.10572
Popis: 10572 Background: In STS third line treatment is poorly defined. However many patients (pts), after aggressive therapy as first and second line progress in their disease ask to be treated. Oral cyclophosphamide (CPM) was already used in breast cancer, prostate cancer and in elderly pts with STS with favourable results. Aim of our study was to define the feasibility, tolerability and activity of oral CPM as third line and further line chemotherapy Methods: 45 pts (19 M; 26 F) with advanced or metastatic STS heavily pretreated were included. Oral CPM was given daily at total dose of 50 mg/day without interruption excepted for toxicity or progressive disease Results: Median age was 60 (32-81), histological subtypes were: leiomyosarcoma 12, liposarcoma 10, condrosarcoma 5, sinovialsarcoma 4, sarcoma NOS 4, other 10. Primary sites were: extremities 21, retroperitoneum 19, trunk 5. 41 pts were metastatic, 4 locally advanced. 41 pts were pretreated with chemotheraphy (15 were in II line, 17 in III line, 7 in IV line, 2 in V line). Median PS (ECOG) was 2 . Median duration of theraphy was 4 months (1-38). Progression free survival (PFS) ranged from 0 to 42+ months (median 4 months). Treatment was well tolerated, we registred only one episode of leucopenia G2 and one of asthenia G2. No complete responses were seen. Only 3 minimal responses and 18 stable disease were seen. Conclusions: Oral CPM showed a mild activity and good tolerability in advanced soft tissue and metastatic STS. It could be an appropriate solution as second line and further therapy and in unfit or elderly pts.
Databáze: OpenAIRE
Externí odkaz: